Literature DB >> 3547886

Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune.

I Cockburn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3547886

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

1.  Skin cancer in an Irish renal transplant population.

Authors:  J F Bourke; G J Mellott; M Young; J Donohoe; M Carmody; J A Keogh
Journal:  Ir J Med Sci       Date:  1992-04       Impact factor: 1.568

2.  A practical approach to treating autoimmune bullous disorders with systemic medications.

Authors:  Anne Han
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

3.  Cancer after transplantation.

Authors:  A M MacLeod; G R Catto
Journal:  BMJ       Date:  1988-07-02

Review 4.  Diagnostic dilemma in pancreatic lymphoma. Case report and review.

Authors:  E Cario; M Rünzi; K Metz; P Layer; H Goebell
Journal:  Int J Pancreatol       Date:  1997-08

5.  Suramin inhibits the mixed lymphocyte reaction by suppressing lymphokine production.

Authors:  M Shenoy; B MacPherson; P Christadoss
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

6.  Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.

Authors:  W J Sandborn; R H Wiesner; W J Tremaine; N F Larusso
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

Review 7.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

8.  Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.

Authors:  D S Snyder; D O Findley; S J Forman; A P Nademanee; M R O'Donnell; G M Schmidt; P J Bierman; J L Fahey; R A Krance; I J Sniecinski
Journal:  Blut       Date:  1988-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.